您的位置: 首页 > 农业专利 > 详情页

Uses of myostatin antagonists, combinations containing them and uses thereof
专利权人:
Novartis AG
发明人:
Klickstein, Lloyd B.,Roubenoff, Ronenn,Feige, Jerome,Trifilieff, Estelle,Hakateyama, Shinji
申请号:
AU2016352806
公开号:
AU2016352806A1
申请日:
2016.11.09
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention relates to myostatin antagonists, for the treatment of cancer cachexia, and cancer cachexia due to chemotherapeutic treatment Especially, the myostatin antagonist bimagrumab was found to be beneficial in the treatment of cancer cachexia by reducing body weight loss. The present invention also relates to combinations and uses of a myostatin antagonist and an mTOR inhibitor for treating cancer cachexia by reducing, maintaining or increasing body weight loss or for use in treating age-related conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充